Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.
Identifieur interne : 000390 ( Main/Corpus ); précédent : 000389; suivant : 000391Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.
Auteurs : Amir Emami ; Fatemeh Javanmardi ; Neda Pirbonyeh ; Ali AkbariSource :
- Archives of academic emergency medicine [ 2645-4904 ] ; 2020.
Abstract
Introduction
In the beginning of 2020, an unexpected outbreak due to a new corona virus made the headlines all over the world. Exponential growth in the number of those affected makes this virus such a threat. The current meta-analysis aimed to estimate the prevalence of underlying disorders in hospitalized COVID-19 patients.
Methods
A comprehensive systematic search was performed on PubMed, Scopus, Web of science, and Google scholar, to find articles published until 15 February 2020. All relevant articles that reported clinical characteristics and epidemiological information of hospitalized COVID-19 patients were included in the analysis.
Results
The data of 76993 patients presented in 10 articles were included in this study. According to the meta-analysis, the pooled prevalence of hypertension, cardiovascular disease, smoking history and diabetes in people infected with SARS-CoV-2 were estimated as 16.37% (95%CI: 10.15%-23.65%), 12.11% (95%CI 4.40%-22.75%), 7.63% (95%CI 3.83%-12.43%) and 7.87% (95%CI 6.57%-9.28%), respectively.
Conclusion
According to the findings of the present study, hypertension, cardiovascular diseases, diabetes mellitus, smoking, chronic obstructive pulmonary disease (COPD), malignancy, and chronic kidney disease were among the most prevalent underlying diseases among hospitalized COVID-19 patients, respectively.
PubMed: 32232218
PubMed Central: PMC7096724
Links to Exploration step
pubmed:32232218Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.</title>
<author><name sortKey="Emami, Amir" sort="Emami, Amir" uniqKey="Emami A" first="Amir" last="Emami">Amir Emami</name>
<affiliation><nlm:affiliation>Microbiology Department, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Javanmardi, Fatemeh" sort="Javanmardi, Fatemeh" uniqKey="Javanmardi F" first="Fatemeh" last="Javanmardi">Fatemeh Javanmardi</name>
<affiliation><nlm:affiliation>Microbiology Department, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pirbonyeh, Neda" sort="Pirbonyeh, Neda" uniqKey="Pirbonyeh N" first="Neda" last="Pirbonyeh">Neda Pirbonyeh</name>
<affiliation><nlm:affiliation>Microbiology Department, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Akbari, Ali" sort="Akbari, Ali" uniqKey="Akbari A" first="Ali" last="Akbari">Ali Akbari</name>
<affiliation><nlm:affiliation>Department of Anesthesiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32232218</idno>
<idno type="pmid">32232218</idno>
<idno type="pmc">PMC7096724</idno>
<idno type="wicri:Area/Main/Corpus">000390</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000390</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.</title>
<author><name sortKey="Emami, Amir" sort="Emami, Amir" uniqKey="Emami A" first="Amir" last="Emami">Amir Emami</name>
<affiliation><nlm:affiliation>Microbiology Department, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Javanmardi, Fatemeh" sort="Javanmardi, Fatemeh" uniqKey="Javanmardi F" first="Fatemeh" last="Javanmardi">Fatemeh Javanmardi</name>
<affiliation><nlm:affiliation>Microbiology Department, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Pirbonyeh, Neda" sort="Pirbonyeh, Neda" uniqKey="Pirbonyeh N" first="Neda" last="Pirbonyeh">Neda Pirbonyeh</name>
<affiliation><nlm:affiliation>Microbiology Department, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Akbari, Ali" sort="Akbari, Ali" uniqKey="Akbari A" first="Ali" last="Akbari">Ali Akbari</name>
<affiliation><nlm:affiliation>Department of Anesthesiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">Archives of academic emergency medicine</title>
<idno type="eISSN">2645-4904</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>Introduction</b>
</p>
<p>In the beginning of 2020, an unexpected outbreak due to a new corona virus made the headlines all over the world. Exponential growth in the number of those affected makes this virus such a threat. The current meta-analysis aimed to estimate the prevalence of underlying disorders in hospitalized COVID-19 patients.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Methods</b>
</p>
<p>A comprehensive systematic search was performed on PubMed, Scopus, Web of science, and Google scholar, to find articles published until 15 February 2020. All relevant articles that reported clinical characteristics and epidemiological information of hospitalized COVID-19 patients were included in the analysis.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Results</b>
</p>
<p>The data of 76993 patients presented in 10 articles were included in this study. According to the meta-analysis, the pooled prevalence of hypertension, cardiovascular disease, smoking history and diabetes in people infected with SARS-CoV-2 were estimated as 16.37% (95%CI: 10.15%-23.65%), 12.11% (95%CI 4.40%-22.75%), 7.63% (95%CI 3.83%-12.43%) and 7.87% (95%CI 6.57%-9.28%), respectively.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Conclusion</b>
</p>
<p>According to the findings of the present study, hypertension, cardiovascular diseases, diabetes mellitus, smoking, chronic obstructive pulmonary disease (COPD), malignancy, and chronic kidney disease were among the most prevalent underlying diseases among hospitalized COVID-19 patients, respectively.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32232218</PMID>
<DateRevised><Year>2020</Year>
<Month>06</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2645-4904</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>8</Volume>
<Issue>1</Issue>
<PubDate><Year>2020</Year>
</PubDate>
</JournalIssue>
<Title>Archives of academic emergency medicine</Title>
<ISOAbbreviation>Arch Acad Emerg Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis.</ArticleTitle>
<Pagination><MedlinePgn>e35</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="Introduction" NlmCategory="UNASSIGNED">In the beginning of 2020, an unexpected outbreak due to a new corona virus made the headlines all over the world. Exponential growth in the number of those affected makes this virus such a threat. The current meta-analysis aimed to estimate the prevalence of underlying disorders in hospitalized COVID-19 patients.</AbstractText>
<AbstractText Label="Methods" NlmCategory="UNASSIGNED">A comprehensive systematic search was performed on PubMed, Scopus, Web of science, and Google scholar, to find articles published until 15 February 2020. All relevant articles that reported clinical characteristics and epidemiological information of hospitalized COVID-19 patients were included in the analysis.</AbstractText>
<AbstractText Label="Results" NlmCategory="UNASSIGNED">The data of 76993 patients presented in 10 articles were included in this study. According to the meta-analysis, the pooled prevalence of hypertension, cardiovascular disease, smoking history and diabetes in people infected with SARS-CoV-2 were estimated as 16.37% (95%CI: 10.15%-23.65%), 12.11% (95%CI 4.40%-22.75%), 7.63% (95%CI 3.83%-12.43%) and 7.87% (95%CI 6.57%-9.28%), respectively.</AbstractText>
<AbstractText Label="Conclusion" NlmCategory="UNASSIGNED">According to the findings of the present study, hypertension, cardiovascular diseases, diabetes mellitus, smoking, chronic obstructive pulmonary disease (COPD), malignancy, and chronic kidney disease were among the most prevalent underlying diseases among hospitalized COVID-19 patients, respectively.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Emami</LastName>
<ForeName>Amir</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Microbiology Department, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Javanmardi</LastName>
<ForeName>Fatemeh</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Microbiology Department, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Pirbonyeh</LastName>
<ForeName>Neda</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>Microbiology Department, Burn and Wound Healing Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Akbari</LastName>
<ForeName>Ali</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Anesthesiology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>03</Month>
<Day>24</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Iran</Country>
<MedlineTA>Arch Acad Emerg Med</MedlineTA>
<NlmUniqueID>101740147</NlmUniqueID>
<ISSNLinking>2645-4904</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword>
<Keyword MajorTopicYN="N">Comorbidity</Keyword>
<Keyword MajorTopicYN="N">Meta-analysis</Keyword>
<Keyword MajorTopicYN="N">severe acute respiratory syndrome coronavirus 2</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>4</Month>
<Day>2</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32232218</ArticleId>
<ArticleId IdType="pmc">PMC7096724</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Radiology. 2020 Feb 21;:200490</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32083985</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Allergy. 2020 Feb 19;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32077115</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>BMJ. 2020 Feb 19;368:m606</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32075786</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2020 Feb 29;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32109279</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Feb 7;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2020 Feb 15;201(4):P7-P8</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32004066</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Can J Anaesth. 2020 May;67(5):568-576</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32052373</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Mar 24;323(12):1122</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32207769</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Chin Med J (Engl). 2020 May 5;133(9):1025-1031</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32044814</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Euro Surveill. 2020 Feb;25(8):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32127124</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2020 Feb 07;69(5):140-146</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32027631</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):470-473</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986257</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Viruses. 2020 Feb 10;12(2):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32050635</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Infect Dev Ctries. 2020 Jan 31;14(1):1-2</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32088678</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>N Engl J Med. 2020 Apr 30;382(18):1708-1720</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32109013</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Digit Health. 2020 Apr;2(4):e201-e208</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32309796</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Antimicrob Agents. 2020 Mar;55(3):105924</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32081636</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Zhonghua Yan Ke Za Zhi. 2020 Feb 20;56(0):E004</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32077665</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Travel Med Infect Dis. 2020 Jan - Feb;33:101578</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32044389</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Epidemiol. 2014 Oct 10;6:359-68</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25336990</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Int J Infect Dis. 2016 Aug;49:129-33</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27352628</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Oncol. 2020 Mar;21(3):335-337</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32066541</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Travel Med. 2020 Mar 13;27(2):</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32052846</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):497-506</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31986264</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Mil Med Res. 2020 Feb 6;7(1):4</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32029004</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet Oncol. 2020 Apr;21(4):e180</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32142622</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Sci China Life Sci. 2020 Mar;63(3):364-374</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32048163</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Clin Infect Dis. 2018 Jan 6;66(1):45-53</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29020176</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 15;395(10223):507-513</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32007143</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2020 Jan 23;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31971553</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Lancet. 2020 Feb 22;395(10224):e40</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32035511</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nat Rev Cardiol. 2020 May;17(5):259-260</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32139904</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CardioCovidV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000390 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000390 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CardioCovidV1 |flux= Main |étape= Corpus |type= RBID |clé= pubmed:32232218 |texte= Prevalence of Underlying Diseases in Hospitalized Patients with COVID-19: a Systematic Review and Meta-Analysis. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Corpus/RBID.i -Sk "pubmed:32232218" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd \ | NlmPubMed2Wicri -a CardioCovidV1
![]() | This area was generated with Dilib version V0.6.35. | ![]() |